AOM also today announced that they are beginning another AMD070 trial today. AOM should be releasing some results from the earlier Ib/IIa trial at the following conference:
One last Canadian pump, Labopharm, DDS seems to be on a good upswing based on its beginning commercialization in Europe of once daily Tramadol. DDS should be announcing some news as to a FDA filing in the very near future. Also DDS had started another Phase III trial and should be announcing results?
DDS had earlier ran two FDA trials but one trial failed due to a high placebo effect. DDS had stated that they intend to file for FDA approval very shortly but also at the same time stated something to the effect that they will release Phase III results when they deem fit. Not sure how they could put the new Phase III data in the NDA unless it is a rollong submission?? DDS has a partnership with Purdue. BVF should be rolling out once daily tramadol in the U.S. very shortly with their partner J&J.